Filter
1326
Filtered Results: 1326
Text search:
biological
agents
Featured
Recommendations
141
New Publications
317
Language
Document type
No document type
722
Guidelines
234
Studies & Reports
205
Manuals
88
Strategic & Response Plan
29
Training Material
18
Fact sheets
17
Brochures
3
Situation Updates
3
Resource Platforms
2
Infographics
2
Online Courses
2
Dashboards/Maps
1
Countries / Regions
India
81
Global
57
Kenya
39
Nigeria
31
Sierra Leone
28
Africa
26
Ethiopia
25
South Africa
24
Western and Central Europe
21
Liberia
21
Tanzania
19
Uganda
19
Latin America and the Carribbean
17
Nepal
16
Bangladesh
14
Ghana
13
Philippines
13
Rwanda
11
Syria
11
Zimbabwe
10
Congo, Democratic Republic of
10
Zambia
10
Malawi
9
USA
9
South–East Asia Region
9
West and Central Africa
8
Eastern Europe
8
Brazil
8
Namibia
8
Ukraine
7
Mozambique
7
Cambodia
7
Germany
7
Lesotho
6
Guinea
6
Myanmar / Burma
6
Albania
5
Burkina Faso
5
Tajikistan
4
East and Southern Africa
4
South Sudan
4
Senegal
3
Eastern Europe and Central Asia
3
Paraguay
3
Spain
3
Vietnam
3
Mali
3
Angola
3
Eswatini/ Swaziland
3
Timor Leste/ East Timor
2
Thailand
2
China
2
Peru
2
Haiti
2
Guinea-Bissau
2
Venezuela
2
Lebanon
2
Sri Lanka
2
Libya
2
Botswana
2
Indonesia
2
Iraq
2
Pakistan
2
North Macedonia
1
Turkey
1
Cameroon
1
Iran
1
Singapore
1
Laos
1
Estonia
1
Niger
1
Mongolia
1
Asia
1
Middle East and North Africa
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Papua New Guinea
1
Moldova
1
Russia
1
Romania
1
Palestine
1
Authors & Publishers
Publication Years
Category
Countries
423
Clinical Guidelines
143
Public Health
86
Key Resources
72
Pharmacy & Technologies
49
Women & Child Health
40
Capacity Building
22
Toolboxes
Planetary Health
92
Rapid Response
83
COVID-19
83
Mental Health
76
HIV
70
TB
69
AMR
69
Ebola
56
Pharmacy
54
NTDs
48
Specific Hazards
43
Conflict
26
Caregiver
25
NCDs
25
Global Health Education
21
Natural Hazards
16
Refugee
14
Zika
14
Disability
11
Cholera
7
Polio
6
Social Ethics
4
Health Financing Toolbox
2
South Sudan
1
Just about everyone has experienced the joy that a healthy newborn child brings to parents, families and communities. But the arrival of a newborn who is small or sick often results in immediate worry and sadness. When the infant is at high risk of death or disability, these concerns can be a tremen...
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
A new publication - Waste Management during the COVID-19 Pandemic: from response to recovery - reviews current practices for managing waste from healthcare facilities, households and quarantine locations accommodating people with confirmed or suspected cases of COVID-19. Jointly produced by UNEP, th...
Malaria Journal (2018) 17:460 https://doi.org/10.1186/s12936-018-2606-9
In malaria endemic countries, asymptomatic cases constitute an important reservoir of infections sustaining transmission. Estimating the burden of the asymptomatic population and identifying areas with elevated risk is import...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended
The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing ...
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
Con esta guía de referencia rápida podrán reconocer con facilidad las enfermedades y efectos secundarios relacionados con el cambio climático, administrar los tratamientos adecuados y aconsejar a las poblaciones expuestas, presentar información actualizada sobre la relación entre los efectos s...
The present Community Empowerment Manual draws upon the lessons learned of the Community Protection Approach implementation in Lebanon, the occupied Palestinian territory and Central America during the period 2015-2020 by WeWorld – GVC and its partners.
The Manual means to accompany Field Staff i...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
Overview.
The COVID-19 pandemic is the latest crisis facing the world, but unless humans release their grip on nature, it won’t be the last, according to a new report by the United Nations Development Programme (UNDP), which includes a new experimental index on human progress that takes into acco...
An Evidence-Based Treatment Guide for Clinicians
MOH clinical practice guidelines
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
